Application
Fig1: Western blot analysis of MRPL42 on human MRPL42 recombinant protein using anti-MRPL42 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of MRPL42 on HEK293 (1) and MRPL42-hIgGFc transfected HEK293 (2) cell lysate using anti-MRPL42 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of MRPL42 on different cell lysate using anti-MRPL42 antibody at 1/1,000 dilution.
Positive control:
Line1:HL7702 Line2:HepG2 Line3:SMMC-7721
Line4:HEK293 Line5:HeLa Line6:Raji
Application
Fig4: ICC staining MRPL42 (green) in HeLa cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti-MRPL42 antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-MRPL42 antibody. Counter stained with hematoxylin.
Application
Fig7: Flow cytometric analysis of HepG2 cells with MRPL42 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).